Abate AS Industries Limited has filed regulatory disclosures regarding a significant share transfer involving substantial acquisition norms, in compliance with SEBI's insider trading and takeover regulations. The company submitted disclosures under both Regulation 7(2) of SEBI Prohibition of Insider Trading Regulations, 2015, and Regulation 29 of SEBI Substantial Acquisition of Shares and Takeovers Regulations, 2011.

Share Transfer Transaction Details

The disclosure reveals a substantial share transfer where Asya, identified as an immediate relative of the promoter, acquired 70,92,291 equity shares representing a 4.50% stake in the company. The transaction was executed as an off-market transfer on March 23, 2026, with the regulatory filing submitted to BSE Limited on March 25, 2026.

Seller Information and Holdings

The shares were transferred from Fazil Chemmankuzhiyil, who does not belong to the promoter group. Prior to this disposal, Fazil held 2,30,34,956 shares representing 14.62% of the company's total voting capital. Following the transfer of 70,92,291 shares, his remaining holding stands at 1,59,42,665 shares, constituting 10.12% of the total equity.

Company Capital Structure

The company's equity share capital remains unchanged at Rs.1,57,60,64,560 both before and after the transaction. The total diluted share capital also stands at the same amount, indicating no convertible securities or warrants are outstanding that could affect the shareholding percentages.

Regulatory Compliance Framework

The dual disclosure under SEBI regulations demonstrates the company's commitment to transparency. The filing under Regulation 29 of the takeover regulations was necessary as the transaction involved substantial acquisition thresholds, while the insider trading regulation disclosure ensures proper reporting of promoter group transactions. Heena Kausar Mohd Amin Rangari, serving as Company Secretary and Compliance Officer (ACS: 49820), executed both regulatory filings, maintaining the company's compliance standards with stock exchange requirements.

Abate AS Industries Ltd has announced a significant technological advancement with the launch of the Alcon Vision Suite (AVS) at Abate Eye Hospital, marking the first installation of this sophisticated ophthalmic technology in Kerala. The announcement was made on 24th March 2025, positioning the hospital at the forefront of advanced eye care in the region.

Revolutionary Technology Integration

The Alcon Vision Suite represents a comprehensive digital ecosystem designed to transform ophthalmic care delivery. The system seamlessly connects and synchronizes every stage of the surgical journey, from initial diagnostics through surgical planning to operating room visualization and postoperative care.

Advanced Features and Capabilities

The AVS installation brings several breakthrough capabilities to Kerala's ophthalmic care landscape:

• Advanced 3D visualization for enhanced surgical accuracy
• Personalized digital surgical planning capabilities
• Reduced variability and improved refractive outcomes
• Greater operating room efficiency
• More predictable and tailored patient results
• Enhanced training capabilities for young ophthalmologists

Leadership Vision and Strategic Impact

Mr. Arikuzhiyan Samsudeen, Chairman and Non-Executive Director, emphasized the transformative nature of this technology implementation. He stated that healthcare is entering a new era where precision, predictability, and patient experience are driven by technology. The introduction of Kerala's first Alcon Vision Suite represents a redefinition of the entire ophthalmic care journey, reflecting the organization's commitment to bringing world-class, technology-led eye care to patients while empowering the next generation of ophthalmologists.

Clinical Applications and Benefits

The AVS technology enables significant improvements in cataract and glaucoma surgeries, providing more accurate, efficient, and patient-focused care. This technological leap strengthens Abate Eye Hospital's position as a center of excellence in ophthalmology, supporting both advanced patient care and comprehensive medical training programs.

Organizational Profile and Global Reach

Abate AS Industries operates as a publicly listed eye care and education institution, building an integrated ophthalmology ecosystem that combines advanced clinical care with talent development. The organization delivers technology-enabled ophthalmic services through experienced specialists, state-of-the-art diagnostic and surgical technology, and maintains a strong commitment to patient-centered care.

The institution serves a growing international patient base spanning Europe, the GCC, and Africa, continuously expanding its reputation for reliable, high-quality treatment while maintaining strong governance standards as a listed healthcare company. Beyond clinical services, the organization integrates education and training to strengthen the pipeline of skilled eye care professionals, building a sustainable ecosystem that advances patient care and drives long-term institutional growth.